Individualized support for informal caregivers of people with dementia – effectiveness of the German adaptation of REACH II

Autor: Martin Berwig, Stephanie Heinrich, Jenny Spahlholz, Nina Hallensleben, Elmar Brähler, Hermann-Josef Gertz

Publikováno v: BMC Geriatrics, Vol 17, Iss 1, Pp 1-13 (2017)

Abstract Background Individualized, outreach and structured multicomponent interventions are a promising intervention approach to relieve the burden of informal caregivers of people with dementia. In this study, we adapted and evaluated a multicompon

Externí odkaz: https://doaj.org/article/2afa03ca86094d8ab821748e5887044e

Correction: Cerebrospinal Fluid Melanin-Concentrating Hormone (MCH) and Hypocretin-1 (HCRT-1, Orexin-A) in Alzheimer’s Disease.

Autor: Frank M. Schmidt, Juergen Kratzsch, Hermann-Josef Gertz, Mandy Tittmann, Ina Jahn, Uta-Carolin Pietsch, Udo X. Kaisers, Joachim Thiery, Ulrich Hegerl, Peter Schönknecht

Publikováno v: PLoS ONE, Vol 8, Iss 6 (2013)

Externí odkaz: https://doaj.org/article/6b24f9773e324dfe966117cd757c5508

(+)-[18F]Flubatine as a novel α4β2 nicotinic acetylcholine receptor PET ligand—results of the first-in-human brain imaging application in patients with β-amyloid PET-confirmed Alzheimer’s disease and healthy controls

Autor: Henryk Barthel, Jörg Steinbach, Steffen Fischer, René Smits, Diego Cecchin, Osama Sabri, Bernhard Sattler, Marianne Patt, Solveig Tiepolt, Julia Luthardt, Georg-Alexander Becker, Alexander Hoepping, Gudrun Wagenknecht, Hermann-Josef Gertz, Michael Rullmann, Friedrich-Alexander Ludwig, Winnie Deuther-Conrad, Peter Brust, S Wilke, Philipp Meyer, Swen Hesse

Publikováno v: European journal of nuclear medicine and molecular imaging 48(3), 731-746 (2021). doi:10.1007/s00259-020-05029-w
European Journal of Nuclear Medicine and Molecular Imaging

Purposes We present the first in-human brain PET imaging data of the new α4β2 nicotinic acetylcholine receptor (nAChR)–targeting radioligand (+)-[18F]Flubatine. Aims were to develop a kinetic modeling-based approach to quantify (+)-[18F]Flubatine

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4fe5c48d1937d5e2d608c7de7a3b37fb
https://doi.org/10.1007/s00259-020-05029-w

Rechtlicher Rahmen: Einwilligungsfähigkeit und ihre Substitute, Fahrtauglichkeit

Autor: Hermann-Josef Gertz

Publikováno v: Praxishandbuch Gerontopsychiatrie und-Psychotherapie

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e2b6f9bdd02ff63b88afce63dd007133
https://doi.org/10.1016/b978-3-437-24436-0.00007-4

Dual Time-Point [18F]Florbetaben PET Delivers Dual Biomarker Information in Mild Cognitive Impairment and Alzheimer’s Disease

Autor: Matthias L. Schroeter, Karl-Titus Hoffmann, Thies H. Jochimsen, Dorothee Saur, Julia Luthardt, Jörg Berrouschot, Bernhard Sattler, Osama Sabri, Joseph Classen, Lisa Florek, Marianne Patt, Hermann-Josef Gertz, Arno Villringer, Solveig Tiepolt, Swen Hesse, Henryk Barthel

Publikováno v: Journal of Alzheimer's Disease. 66:1105-1116

BACKGROUND Current research diagnostic criteria for Alzheimer's disease (AD) and mild cognitive impairment (MCI) due to AD include biomarkers to supplement clinical testing. Recently, we demonstrated that dual time-point [18F]FBB PET is able to deliv

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21a484ca822d85f65bfbd0da226e7e1c
https://doi.org/10.3233/jad-180522